Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Learn when bonds may outperform stocks for retirement, with practical timing cues and risk considerations.
24,889 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
A Goldman Sachs note presents a bullish scenario where gold could hit $5,400 per ounce. The outlook reverberates thro...
SoundHound AI faced a sharp stock move after a major leadership change. This article breaks down what happened, why i...
A geopolitical chokepoint isn't just about oil. The Strait of Hormuz also moves a vital portion of global fertilizer....
When a mid-cap medical device stock vaults over 5 percent in a single session, investors sit up and take notice. This...
The Roundhill Magnificent Seven ETF (MAGS) now provides one-ticker exposure to seven mega-cap AI leaders. It uses equ...
A respected advisory firm recently trimmed its stake in Peabody Energy, nudging the stock and sparking questions abou...
Copper-focused funds tumbled as Broadcom signaled slower AI semiconductor demand. COPJ fell 11% in a single session, ...
When a founder makes a sky‑high forecast, investors scramble. This article breaks down elon musk just made claims abo...
Lineage and Rexford Industrial Realty offer starkly different paths in industrial real estate. This guide breaks down...
Investors are debating whether to own the entire global stock universe or focus on U.S. equities via VTI in a 2026 ma...
The S&P 500 has posted a double-digit gain this year, even as a cash-flow focused ETF shows a different path, drawing...